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No exceptionalism for informed consent in psy-
chotherapy
We welcome the debate on informed consent in psy-
chotherapy, which has been long overdue [1]. However, a
general statement ascertaining that informed consent is an
ethical and legal requirement in all fields of modern med-
icine including psychotherapy is not enough; practitioners
and researchers need to probe how this requirement can
best be implemented in clinical practice.
This is why it is important to acknowledge the challenges
that specific psychotherapeutic approaches may encounter.
One challenge that has been discussed with regard to in-
formed consent in psychotherapy is the exploratory nature
of psychodynamic approaches. As a possible response, a
“procedural consent” was cited according to which “con-
sequences and constituents of psychotherapy are only dis-
closed after some psychotherapy has transpired, for exam-
ple, if they are clinically relevant” [2].
This is not convincing. Vaguely gesturing towards the “in-
trinsic uncertainty” of psychodynamic psychotherapy can-
not serve as a justification for keeping patients out of the
loop. It is correct that often informed consent needs to be
a process rather than a one-stop shop. This is not only nec-
essary for psychodynamic psychotherapy but also for any
other insight- and clarification-oriented approach. Howev-
er, patients who invest their time and, many times, their
money and who carry the risk of any damage that may re-
sult from treatments have the right to know a number of
facts before committing to an intervention, and not some
time along the way. This does not preclude patients chang-
ing their mind or requesting additional information once
they have embarked on the therapeutic experience.
Among the aspects that need to be addressed are: the nature
and goal of the psychotherapeutic intervention; the method
that is being applied; the probability of success (at least an
estimate and what it is based on); the frequency and dura-
tion of sessions; the approximate duration of the treatment;
the costs incurred; confidentiality and its limits; risks and
unintended effects, as well as the emotional burden caused
by the psychotherapy; therapeutic alternatives; and options
to interrupt or stop the intervention [3, 4].
If any of these aspects of informed consent are uncertain at
the outset of psychotherapy, this needs to be discussed with
the patient. Other psychotherapeutic approaches such as
cognitive-behavioural therapy, existential-humanistic ther-
apy or systemic therapy, as well as other areas in medicine
more broadly, also struggle with considerable degrees of
uncertainty, for example regarding outcomes. Yet this does
not serve as a justification for an ethical exceptionalism.
When dealing with practical issues of how to best imple-
ment the informed consent requirement, it might be of in-
terest to note the recent move away from informing the
patient and getting his or her consent towards the con-
cept of shared decision-making [5]. Shared decision-mak-
ing is considered a stepwise procedure between patient and
provider that aims to enable evidence-based patient choice
through a process of listening, informing, discussing, de-
ciding, and documenting [6]. This process allows a nego-
tiation of what the patient expects and is willing to in-
vest and what the provider is able and willing to offer.
Acknowledging and dealing with uncertainties is a regular
part of this process.
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